<< Back

Jim Fortune

Chief Operating Officer
Jim Fortune has more than 25 years of senior operating experience in both public and private companies within the healthcare sector. He joined Ocular Therapeutix in 2008, also serving as Chief Operating Officer of Augmenix from 2008 until April 2014 and as COO of AccessClosure from 2008 to 2010. Previously, Mr. Fortune served in COO positions at Intrinsic Therapeutics and, prior to this, at Confluent Surgical. He also had a 17-year career in management roles of increasing responsibility within the orthopedic and neurosurgical divisions of Johnson & Johnson.

Mr. Fortune received a B.S. degree in mechanical engineering from Rensselaer Polytechnic Institute.